Candel Therapeutics

About:

Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.

Website: https://www.candeltx.com

Twitter/X: CandelTx

Top Investors: Sands Capital Ventures, Massachusetts Life Sciences Center, Silicon Valley Bank, Northpond Ventures, PBM Capital Group

Description:

Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.

Total Funding Amount:

$165M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Needham, Massachusetts, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)candeltx.com

Founders:

Estuardo Aguilar-Cordova

Number of Employees:

11-50

Last Funding Date:

2022-03-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai